SCHEMBL10184008

SCHEMBL10184008

O=C1C(N(C(=O)COc2cccnc2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGIR P43119 2/20 0.38
▸ USP2 O75604 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TRPM8 Q7Z2W7 3/20 0.36
▸ TP53 P04637 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ VCP P55072 1/20 0.34
▸ FPR1 P21462 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ OPRM1 P35372 2/20 0.33
▸ OPRK1 P41145 2/20 0.33
▸ OPRL1 P41146 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183761 0.91 TRPM8 (0.42) TRPM8TP53ALDH1A1OPRM1OPRK1
SCHEMBL10185587 0.89 TRPM8 (0.41) PTGIRTRPM8ALDH1A1OPRM1OPRK1
SCHEMBL10183973 0.87 TRPM8 (0.38) TRPM8ALDH1A1OPRM1OPRK1OPRL1
SCHEMBL10185957 0.86 TSHR (0.43) PTGIRUSP2TSHRTP53KDM4E
SCHEMBL10185551 0.86 NPC1 (0.37) TRPM8KDM4EALDH1A1OPRM1OPRK1
SCHEMBL10184119 0.83 OPRM1 (0.37) PTGIRTRPM8TP53CYP1A2CYP3A4
SCHEMBL10185933 0.83 GRM5 (0.40) PTGIRUSP2TSHRKDM4EOPRM1
SCHEMBL10185558 0.83 NPC1 (0.36) PTGIRTSHRKDM4EALDH1A1OPRM1
SCHEMBL10183676 0.82 HCRTR1 (0.35) TRPM8OPRM1OPRK1OPRL1MAPT
SCHEMBL10183299 0.82 OPRM1 (0.40) PTGIRTP53OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback